Literature DB >> 15709484

Clusterin and Alzheimer's disease.

Miguel Calero1, Agueda Rostagno, Blas Frangione, Jorge Ghiso.   

Abstract

Clusterin (apolipoprotein J) is a ubiquitous multifunctional glycoprotein with the capability to interact with a broad spectrum of molecules, among them the Alzheimer's Abeta peptide. Due to its co-localization with fibrillar deposits in systemic and cerebral amyloid disorders, clusterin is also considered an amyloid-associated protein. Although no genuine function has been attributed to this protein so far, it has been implicated in a wide variety of physiological and pathological processes, a role that may vary according to the protein maturation, sub-cellular localization, and the presence of certain tissue- or cell-specific factors. This review focuses on the importance of clusterin in health and disease conditions, with particular emphasis in its role in Abeta amyloidosis and other disorders of protein folding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709484

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  26 in total

Review 1.  Genetics of dementia.

Authors:  Henry L Paulson; Indu Igo
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

2.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

3.  Identification of putative retinoic acid target genes downstream of mesenchymal Tbx1 during inner ear development.

Authors:  Dennis C Monks; Bernice E Morrow
Journal:  Dev Dyn       Date:  2012-02-01       Impact factor: 3.780

4.  Inhibition of Abeta42 aggregation using peptides selected from combinatorial libraries.

Authors:  Michael Baine; Daniel S Georgie; Elelta Z Shiferraw; Theresa P T Nguyen; Luiza A Nogaj; David A Moffet
Journal:  J Pept Sci       Date:  2009-08       Impact factor: 1.905

5.  CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment.

Authors:  Antonio Scollato; Alessandro Terreni; Anna Caldini; Benedetta Salvadori; Pasquale Gallina; Simona Francese; Guido Mastrobuoni; Giuseppe Pieraccini; Gloriano Moneti; Luca Bini; Gianni Messeri; Nicola Di Lorenzo
Journal:  Neurol Sci       Date:  2009-11-21       Impact factor: 3.307

6.  Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Georgianne F Tiu; Nicole N Scheff; Marzia Perluigi; Chiara Cini; D Allan Butterfield
Journal:  Brain Res       Date:  2010-04-01       Impact factor: 3.252

Review 7.  Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.

Authors:  Xiang Li; Yifei Ma; Xu Wei; Yanpeng Li; Huijuan Wu; Jianhua Zhuang; Zhongxin Zhao
Journal:  Neurosci Bull       Date:  2013-12-19       Impact factor: 5.203

8.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

9.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

Review 10.  Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.

Authors:  Audrey M Bernstein; Robert Ritch; Jose M Wolosin
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.